Skeletal infections: microbial pathogenesis, immunity and clinical management
EA Masters, BF Ricciardi, KLM Bentley… - Nature Reviews …, 2022 - nature.com
Osteomyelitis remains one of the greatest risks in orthopaedic surgery. Although many
organisms are linked to skeletal infections, Staphylococcus aureus remains the most …
organisms are linked to skeletal infections, Staphylococcus aureus remains the most …
Antibiotic approvals in the last decade: are we keeping up with resistance?
EB Chahine, JA Dougherty… - Annals of …, 2022 - journals.sagepub.com
Objective: To review the spectrum of activity, efficacy, safety, and role in therapy of all
antibiotics and related biologics approved by the Food and Drug Administration (FDA) in the …
antibiotics and related biologics approved by the Food and Drug Administration (FDA) in the …
The application of the CRISPR-Cas system in antibiotic resistance
S Tao, H Chen, N Li, W Liang - Infection and drug resistance, 2022 - Taylor & Francis
The emergence and global epidemic of antimicrobial resistance (AMR) poses a serious
threat to global public health in recent years. AMR genes are shared between bacterial …
threat to global public health in recent years. AMR genes are shared between bacterial …
Emerging treatment options for multi-drug-resistant bacterial infections
R Giurazza, MC Mazza, R Andini, P Sansone, MC Pace… - Life, 2021 - mdpi.com
Antimicrobial resistance (AMR) remains one of the top public health issues of global
concern. Among the most important strategies for AMR control there is the correct and …
concern. Among the most important strategies for AMR control there is the correct and …
Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies
JJP Kouijzer, DJ Noordermeer… - Frontiers in cell and …, 2022 - frontiersin.org
Infective endocarditis (IE) is a life-threatening microbial infection of native and prosthetic
heart valves, endocardial surface, and/or indwelling cardiac device. Prevalence of IE is …
heart valves, endocardial surface, and/or indwelling cardiac device. Prevalence of IE is …
A comprehensive overview of the antibiotics approved in the last two decades: retrospects and prospects
Z Shi, J Zhang, L Tian, L Xin, C Liang, X Ren, M Li - Molecules, 2023 - mdpi.com
Due to the overuse of antibiotics, bacterial resistance has markedly increased to become a
global problem and a major threat to human health. Fortunately, in recent years, various new …
global problem and a major threat to human health. Fortunately, in recent years, various new …
[HTML][HTML] Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis
W Kuang, H Zhang, X Wang, P Yang - Acta Pharmaceutica Sinica B, 2022 - Elsevier
Mycobacterium tuberculosis (MTB) utilizes multiple mechanisms to obtain antibiotic
resistance during the treatment of infections. In addition, the biofilms, secreted by MTB, can …
resistance during the treatment of infections. In addition, the biofilms, secreted by MTB, can …
Phosphate moiety in FDA‐approved pharmaceutical salts and prodrugs
A Fulmali, SS Bharate - Drug Development Research, 2022 - Wiley Online Library
The salification and prodrug approaches modulate the physicochemical properties and
absorption, distribution, metabolism, excretion, and toxicity parameters of drugs and lead …
absorption, distribution, metabolism, excretion, and toxicity parameters of drugs and lead …
Activity of oritavancin against Gram-positive pathogens causing bloodstream infections in the United States over 10 years: focus on drug-resistant enterococcal …
Oritavancin displayed potent and stable activity (MIC90 range of 0.06 to 0.5 mg/L) over a 10-
year period (2010 to 2019) against Gram-positive pathogens that cause bloodstream …
year period (2010 to 2019) against Gram-positive pathogens that cause bloodstream …
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review
G Baiardi, M Cameran Caviglia, F Piras, F Sacco… - Antibiotics, 2023 - mdpi.com
Oritavancin (ORI) is a semisynthetic lipoglycopeptide approved as a single 1200 mg dose
intravenous infusion for the treatment of acute bacterial skin and skin structure infections …
intravenous infusion for the treatment of acute bacterial skin and skin structure infections …